Articles

EAST HILLS, N.Y.--(BUSINESS WIRE)--Jan. 12, 2004--Pall Corporation (NYSE:PLL) announced today that Eric Krasnoff, the Company's Chairman and Chief Executive Officer, will speak at the JP Morgan Healthcare Conference on Wednesday, January 14, 2004 in San Francisco. Also presenting will be Jerold Martin, Senior Vice President and Global Technical Director of Pall's BioPharmaceuticals segment.

The presentation will include the strategies driving Pall's strong performance, including the introduction of new products into burgeoning markets, a growing annuity stream from its systems business and "CORE" cost reduction programs.

They will also present Pall's broad capabilities to supply filtration, separations and purification products for the Life Sciences industries, including medical applications and the entire drug development pipeline of the biotechnology market - from new drug discovery through pilot scale development into full production of new biopharmaceuticals. Pall's Life Sciences business produced $668.9 million, or 41.5% of the Company's $1.614 billion in revenues in fiscal 2003.

Participants may listen to Pall Corporation's live presentation over the internet on Wednesday, January 14th at 5:00 pm ET by going to www.pall.com/investor and clicking on the scrolling text or by going directly to: https://events.jpmorgan.com/healthcare04

Pall Life Sciences

---

• Request Information
• Contact Details
• Company Profile

---